baber/WOPTO huggingface dataset:
Patent AU-2009203714-B2 (AU)
Title: Multi - stage membrane separation process
Inventor: MARTIJN JARWAARDE EWOUT VAN
IPC: B01D53/22
Filed: 2009-01-07
Granted: 2011-11-17
Abstract: The invention concerns a process for the removal of gaseous acidic contaminants, especially carbon dioxide and/or hydrogen sulphide, in two or more stages from a gaseous hydrocarbonaceous feedstream (1) comprising hydrocarbons and said acidic contaminants, using one or more membranes in each separation stages. The gaseous hydrocarbonaceous feedstream is especially a natural gas stream. The process is especially suitable for feedstreams comprising very high amounts of acidic contaminants, especially carbon dioxide, e.g. more than 25 vol. %, or even more than 45 vol. %. In a first stage (2) a pure or almost pure stream of acidic contaminants is separated from the feedstream, the acidic contaminants (4) stream suitably containing less than 5 vol% of hydrocarbons. The remaining stream (3) comprises the hydrocarbons and still a certain amount of gaseous acidic contaminants. In a second stage (5) a pure or almost pure stream of hydrocarbons (8) is separated from the remaining stream, where after the then remaining stream (6) is combined with the feed for the first stage (1), the hydrocarbon stream suitably containing less than 5 vol% of acidic contaminants.
Patent AU-2009275218-B2 (AU)
Title: Substituted-Quinoxaline-Type Bridged-Piperidine Compounds and the uses thereof
Inventor: YAO JIANGCHAO
IPC: C07D403/04
Filed: 2009-07-20
Granted: 2012-11-08
Abstract: The invention relates to Substituted-Quinoxaline-Type Bridged-Piperidine Compounds, compositions comprising an effective amount of a Substituted-Quinoxaline- Type Bridged-Piperidine Compound and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Substituted-Quinoxaline-Type Bridged-Piperidine Compound.
Patent AU-2009308780-B2 (AU)
Title: System and method for facilitating observation of monitored physiologic data
Inventor: VARGAS STEVE
IPC: G16H40/60
Filed: 2009-10-30
Granted: 2013-10-17
Abstract: Present embodiments are directed to a system and method capable of detecting and graphically indicating physiologic patterns in patient data. For example, present embodiments may include a monitoring system that includes a monitor capable of receiving input relating to patient physiological parameters and storing historical data related to the parameters. Additionally, the monitoring system may include a screen capable of displaying the historical data corresponding to the patient physiological parameters. Further, the monitoring system may include a pattern detection feature capable of analyzing the historical data to detect a physiologic pattern in a segment of the historical data and capable of initiating a graphical indication of the segment on the screen when the physiologic pattern is present in the segment.
Patent AU-2010212416-B2 (AU)
Title: RNA interference by modified short interfering nucleic acid
Inventor: DAVID MORRISSEY
IPC: A61P25/00
Filed: 2010-08-18
Granted: 2011-10-20
Abstract: RNA INTERFERENCE BY MODIFIED SHORT INTERFERING NUCLEIC ACID Abstract The present invention concerns methods and reagents useful in modulating gene 5 expression in a variety of applications, including use in therapeutic, diagnostic, target validation, and genomic discovery applications. Specifically, the invention relates to synthetic chemically modified small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules capable of mediating 10 RNA interference (RNAi) against target nucleic acid sequences. The small nucleic acid molecules are useful in the treatment of any disease or condition that responds to modulation of gene expression or activity in a cell, tissue, or organism.
Patent AU-2010213493-B2 (AU)
Title: Duplex cables and zipcord cables and breakout cables incorporating duplex cables
Inventor: HURLEY WILLIAM C
IPC: G02B6/44
Filed: 2010-02-16
Granted: 2015-07-23
Abstract: Interconnect cables utilize bend- insensitive fibers (100) and relatively large free space areas in the cable jackets to reduce bend-induced delta attenuation. Tensile yarns (420) are included as strain-relief components, but can be relatively loosely packed in order to inhibit bend-induced attenuation.
Patent AU-2010255982-B2 (AU)
Title: Osteosynthesis with nano-silver
Inventor: DINGELDEIN ELVIRA
IPC: A61L27/54
Filed: 2010-06-01
Granted: 2014-04-03
Abstract: The present invention relates generally to an antibacterial coating which is composed of silver, to medical tools and to implants comprising such a coating and to a method as well to an apparatus for the production of such a coating. The medical tools or the dental or orthopaedic implant comprises a metal or metal alloy having a treated surface wherein the treated surface is at least partially converted to an oxide film by plasma electrolytic oxidation using a colloid-dispersed system and wherein the converted surface is partially covered by islands formed by colloid-dispersed silver-particles of the colloid-dispersed system. An Ag-TiO
Patent AU-2010258637-B2 (AU)
Title: Communications plugs having capacitors that inject offending crosstalk after a plug-jack mating point and related connectors and methods
Inventor: LARSEN WAYNE D
IPC: H01R24/00
Filed: 2010-06-10
Granted: 2013-08-22
Abstract: Communications plugs are provided that include a plug housing. A plurality of plug contacts are mounted in a row at least partly within the plug housing. The plug contacts are arranged as differential pairs of plug contacts. Each of the differential pairs of plug contacts has a tip plug contact and a ring plug contact. A first capacitor is provided that is configured to inject crosstalk from a first of the tip plug contacts to a first of the ring plug contacts at a point in time that is after the point in time when a signal transmitted through the first of the tip plug contacts to a contact of a mating jack reaches the contact of the mating jack.
Patent AU-2010279264-B2 (AU)
Title: Electrical connector and method of manufacturing same
Inventor: GARB JEFFREY W
IPC: H01R27/00
Filed: 2010-08-06
Granted: 2014-07-31
Abstract: Some embodiments can concern an apparatus configured to provide electrical power received from at least a first electrical outlet or a second electrical outlet. The apparatus can include (a) a housing, (b) at least two electrical outlets at the housing, (c) an electrical coupler at least partially enclosed by the housing and electrically coupled to the at least two third electrical outlets, (d) a first prong adapter configured to removably couple to the electrical coupler and the first electrical outlet, (e) a second prong adapter configured to removably couple to the electrical coupler and the second electrical outlet. The first prong adapter can be configured to receive a first electrical power with a first voltage from the first electrical outlet when the first prong adapter is coupled to the first electrical outlet.
Patent AU-2010292122-B2 (AU)
Title: Containers and methods for dispensing multiple doses of a concentrated liquid, and shelf stable concentrated liquids
Inventor: RAGNARSSON KARL
IPC: B01F15/02
Filed: 2010-09-10
Granted: 2016-06-16
Abstract: Containers (10) and methods are provided for dispensing a liquid concentrate (20) utilizing one or more desirable properties including a generally consistent discharge across a range of squeeze forces, a generally consistent discharge with the same force without significant dependence on the amount of liquid concentrate in the container, a substantially dripless or leak proof outlet opening (31), a jet (34) that minimizes splashing when the liquid concentrate impacts a target liquid (43), and a jet that maximizes mixing between the liquid concentrate and the target liquid to produce a generally homogenous mixture without the use of extraneous utensils or shaking. Also provided are liquid beverage concentrates that can be cold filled during packaging, while maintaining shelf stability for at least twelve months at ambient temperatures. Concentrate can have a combination of low pH and high alcohol content such as a pH less than 3.5 and alcohol content greater than 5 percent by weight.
Patent AU-2010322928-B2 (AU)
Title: Probabilistic simulation of subterranean fracture propagation
Inventor: CRAIG DAVID P
IPC: E21B43/16
Filed: 2010-11-25
Granted: 2015-01-22
Abstract: Systems, methods, and instructions encoded in a computer-readable medium can perform operations related to stochastic simulation of subterranean fracture propagation. A plurality of subterranean formation models, each representing a subterranean formation, are analyzed to obtain information on predicted results of applying an injection treatment to the subterranean formation. Each of the analyzed subterranean formation models is generated by simulating forces acting on rock blocks of the subterranean formation during the injection treatment. Each simulation has an input parameter value determined for that simulation based on sampling a distribution of values for a characteristic of the subterranean formation. The characteristic may include, for example, a natural fracture parameter. The information on the predicted results of applying the injection treatment may include, for example, an output probability distribution. In some implementations, the information may be used to design an injection treatment for the subterranean formation.
Patent AU-2011211337-B2 (AU)
Title: Immunomodulating compositions and uses therefor
Inventor: RALPH STEPHEN JOHN
IPC: A61K38/17
Filed: 2011-08-10
Granted: 2014-10-02
Abstract: C:WNRPonbIDCC\SZP\3793674 I DOC-3/U/201 I The present invention discloses immunomodulating compositions. More particularly, the present invention discloses compositions comprising an immune-modulating agent and a 5 lectin-interactive agent, which are useful for stimulating and prolonging host immune cell responses. The compositions of the present invention are particularly useful in the treatment and/or prophylaxis of a range of conditions including pathogenic infections, autoimmune diseases, transplant rejection, graft versus host disease, allergies, inflammatory disease, as well as cancers and tumours. Combined Survival Curve 6 0 -_ -3 0 10 20 30 40 50 60 Days of survival
Patent AU-2011221774-B2 (AU)
Title: Plant disease controlling composition and method for controlling plant disease
Inventor: KIGUCHI SO
IPC: A01P3/00
Filed: 2011-03-02
Granted: 2015-09-17
Abstract: The present invention provides a composition having an excellent controlling activity on plant disease. The composition comprising the compound represented by the formula (1) and one or more azole fungicidal compound selected from the group (A) shows an excellent controlling activity on a plant disease. group (A): a group consisting of triadimenol, bitertanol, oxpoconazole fumarate, tebuconazole, cyazofamid, pefurazoate, triflumizole, hymexazol, and etridiazole
Patent AU-2011235961-B2 (AU)
Title: Ocular surface interferometry (OSI) devices, systems, and methods for imaging, processing, and/or displaying an ocular tear film and/or measuring ocular tear film layer thickness (ES)
Inventor: KORB DONALD R
IPC: A01N57/26
Filed: 2011-10-11
Granted: 2013-09-26
Abstract: OCULAR SURFACE INTERFEROMETRY (OSI) DEVICES, SYSTEMS, AND METHODS FOR IMAGING, PROCESSING, AND/OR DISPLAYING AN OCULAR TEAR FILM AND/OR MEASURING OCULAR TEAR FILM LAYER THICKNESS(ES) Ocular surface interferometry (OSI) devices 30, systems, and methods are disclosed for measuring a tear film layer thickness (TFLT) of the ocular tear film 46, including lipid layer 1o thickness (LLT) and/or aqueous layer thickness (ALT). The measured TFLT can be used to diagnosis dry eye syndrome (DES). In certain disclosed embodiments, a multi-wavelength light source 36 can be controlled to illuminate the ocular tear film 46. Light emitted from the multi-wavelength light source 36 undergoes optical wave interference interactions in the tear film 46. An imaging device 40 can be focused on the lipid layer 50 of the tear film 46 to is capture optical wave interference interactions of specularly reflected light from the tear film 46 combined with a background signal(s) in a first image 79. The imaging device 40 can also be focused on the lipid layer 50 of the tear film 46 to capture a second image 90 containing the background signal(s) present in the first image 79.
Patent AU-2011252573-B2 (AU)
Title: Afforestation ecological fabric reinforcing method and structure thereof
Inventor: CHANG YU-SHUN
IPC: E02D17/20
Filed: 2011-05-11
Granted: 2015-02-19
Abstract: An afforestation ecological fabric reinforcing method includes the following steps: digging a trench (2) in the area to be afforested; laying a first ecological fabric (3) on the surface (1) of the area to be afforested and in the trench (2); refilling a first part of the soil layer (4) in the trench (2) to press the first ecological fabric (3); and fixing a second ecological fabric (5) on the first part of the soil layer (4) to fix the first part of the soil layer (4) by the second ecological fabric (5) so as to avoid the first part of the soil layer (4) from losing and lead the lateral margins of the second ecological fabric (5) and the first ecological fabric (3) in the trench (2) and the trench (2) to commonly form a bag structure for fixing the first part of the soil layer (4). An afforestation ecological fabric reinforcing structure is also disclosed. The afforestation ecological fabric reinforcing method and structure thereof can effectively stabilize each ecological fabric's connection, have simple and convenient construction, and can be widely suitable for afforestation construction of various geological environments, such as desert, side slopes and wastelands.
Patent AU-2011271382-B2 (AU)
Title: A waveform generator in a multi-chip system
Inventor: KATZ DAVID J
IPC: H04L25/14
Filed: 2011-06-02
Granted: 2014-05-01
Abstract: In one aspect, an integrated circuit (IC) system includes a receiver IC configured to receive a first clock signal and includes a feedback circuit configured to provide a feedback signal to a driver IC. The IC system also includes the driver IC configured to receive a second clock signal and includes a waveform generator configured to provide synthesized waveforms from DC to K-band, a serializer/deserializer (SERDES) to receive data from the waveform generator and to provide the signal to the receiver IC and a phase selection circuit to provide a phase selection signal to the first integrated circuit based on the feedback signal. The phase selection signal calibrates the signal from the SERDES and provides phase correction to the SERDES.
Patent AU-2011271636-B2 (AU)
Title: Low emission power generation systems and methods
Inventor: OELFKE RUSSELL H
IPC: C01B32/50
Filed: 2011-06-09
Granted: 2016-03-17
Abstract: Methods and systems for C0
Patent AU-2011278763-B2 (AU)
Title: Torch
Inventor: OPOLKA RAINER
IPC: F21Y113/20
Filed: 2011-05-05
Granted: 2015-01-29
Abstract: The invention relates to a torch having a rotary switch which serves to switch different degrees of brightness and/or colors of light. Said switch comprises a battery cartridge (15) that is rotatably housed in a torch case (14) and has resiliently received electrical contacts (20, 21) on its face, said contacts being connected to electrical contact surfaces (5) or electrical contact zones (1, 2, 3, 4) of a contact plate (16). The aim of the invention is to devise a torch having different switching states that has a compact design and that can be switched in a simple and reliable manner. For this purpose, the battery cartridge is captively retained in the torch case by means of a locating sleeve (11) and the battery cartridge is rotated by means of a rotary knob (21) that axially extends through the locating sleeve.
Patent AU-2011279392-B2 (AU)
Title: Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-tRNA synthetases
Inventor: GREENE LESLIE ANN
IPC: A61P3/00
Filed: 2011-07-11
Granted: 2017-02-02
Abstract: Provided are compositions comprising newly identified protein fragments of aminoacyl-tRNA synthetases, polynucleotides that encode them and complements thereof, related agents, and methods of use thereof in diagnostic, drug discovery, research, and therapeutic applications.
Patent AU-2011292475-B2 (AU)
Title: Methods and arrangements in cellular communication systems
Inventor: KAZMI MUHAMMAD
IPC: H04W72/04
Filed: 2011-07-05
Granted: 2016-09-22
Abstract: The disclosure relates to methods and arrangements wherein a user equipment (UE) supporting a first frequency band H
Patent AU-2011298226-B2 (AU)
Title: System and method for determination of a brainstem response state development
Inventor: KALLSTRAND JOHAN
IPC: A61B5/0484
Filed: 2011-09-05
Granted: 2014-11-27
Abstract: A system, method and computer program are disclosed that are adapted to detect a lateral brainstem response state development of a subject over a period of time as a function of a population of neurons evoked response patterns to sound stimuli. In these a sound stimuli generating unit is operative to repeatedly send a sound stimulus to the subject to evoke the neurons response patterns. The sound stimulus comprises a first and at least a second consecutive train of sounds pulses. A detection unit is operative to detect a brainstem response signal related to the neurons response patterns, wherein a first response signal is caused by the first train of sound pulses and a second response signal is caused by the second train of sound pulses. A storage unit may be included that is operative to store information based on the brainstem response signals. Further, a control unit is operative to determine the lateral brainstem response state development based on a comparison between the first and second response signals.
Patent AU-2011298315-B2 (AU)
Title: Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
Inventor: ASWANIA OSAMA
IPC: A61P11/06
Filed: 2011-08-31
Granted: 2014-08-28
Abstract: A drug product comprising: a dry powder inhalation device containing one or more pharmaceutical compositions present therein, wherein the one or more pharmaceutical compositions comprise active ingredients (I) 4-{(1R)-2-[(6-{2-[(2,6- dichlorobenzyl)oxy]ethoxy} hexyl)amino]-1-hydroxyethyl}-2- (hydroxymethyl)phenol, or a salt thereof, and (II) (6α,11ß,16α,17α)-6,9-difluoro- 17-{[(fluoromethyl)thio]carbonyl}-11-hydroxy-16-methyl-3-oxoandrosta-1,4-dien- 7-yl 2- furancarboxylate or a solvate thereof; a hygroscopic material; and a package which encompasses the dry powder inhalation device and the hygroscopic material defining an enclosed volume therein; wherein each of the active ingredients (I) and (II) are present in the same or different pharmaceutical compositions, and wherein the enclosed volume within the package exhibits a Relative Humidity of from 20% to 40%.
Patent AU-2011305469-B2 (AU)
Title: Bioabsorbable polymeric compositions, processing methods, and medical devices therefrom
Inventor: KELLY BRIAN M
IPC: C08L67/04
Filed: 2011-09-21
Granted: 2015-02-12
Abstract: Novel bioabsorbable polymeric blends are disclosed. The blends have a first component that is a polylactide polymers or a copolymer of lactide and glycolide and a second component that is poly(
Patent AU-2011317695-B2 (AU)
Title: Device for absorption of noise
Inventor: KONZ OLIVER
IPC: H04B15/02
Filed: 2011-10-13
Granted: 2015-01-15
Abstract: A device for absorption of electrical noise on lines contains a housing which is formed from two half-shells, which are connected to one another with the aid of a film hinge and, in the area of their opposite edges, have a locking device, which locks the two half-shells. A ferrite element is held in each half-shell. An aperture or a window is formed in the wall of one half-shell, through which the locking device can be seen, which locking device acts per se in a depression within the wall. Through this aperture it is possible to check and to inspect whether two elements which form the locking device are correctly seated.
Patent AU-2011329760-B2 (AU)
Title: Stent delivery system
Inventor: HACKER DEAN
IPC: A61F2/95
Filed: 2011-11-17
Granted: 2015-12-03
Abstract: Stent delivery systems, clip members for use with stent delivery systems, and methods for making and using the same are disclosed. An example stent delivery system may include an inner shaft having a distal region. A stent may be disposed about the distal region. A deployment sheath may be slidably disposed about the inner shaft. A handle may be coupled to the inner shaft. The handle may include a clip member having a first holding portion and a second holding portion. The inner shaft may extend through the first holding portion and the second holding portion. A holding cuff may be thermally bonded to the inner shaft. The holding cuff may be positioned between the first holding portion and the second holding portion.
Patent AU-2011333119-B2 (AU)
Title: Scanning confocal endoscope system
Inventor: KOBAYASHI SHOTARO
IPC: A61B1/00
Filed: 2011-09-14
Granted: 2015-07-16
Abstract: The scanning confocal endoscope system is configured from: a point light source that moves cyclically in a two-dimensional plane and scans an excitation ray on the subject; a point light source control means that controls the point light source so that the irradiation density of the excitation light is at or below a prescribed density in the entire scanning region; a confocal pinhole disposed at a position conjugated with the excitation light focal point; an image signal detection means that receives, via the confocal pinhole, fluorescence generated from the subject excited by the excitation light and detects the image signal; and an image-generating means that generates a confocal image using the detected image signal.
Patent AU-2011383743-B2 (AU)
Title: Method, monitoring system and computer program for monitoring use of an absorbent product
Inventor: CARNEY JOSHUA
IPC: A61F13/42
Filed: 2011-12-21
Granted: 2015-04-30
Abstract: The present invention provides a method for monitoring use of an absorbent product (15), such as an incontinence pad or a diaper, worn by a user(14). The method comprises the step of detecting (S4), by means of an odour sensor device (3a;3b) capable of being carried by the user (14) and configured to communicate with a mobile device (2) of the user, at least one chemical indicative of a presence of urine and/or faeces in the product. It further comprises the steps of transmitting (S5) a signal indicative of said detection from the odour sensor device (3a;3b) to the mobile device (2), receiving (S6) the signal in the mobile device (2), and providing (S7), by means of the mobile device, product-related information to the user based on the signal.In this way, the user (14) can be provided with valuable information related to the use of the product (15), for example recommendations on when to change the product, displayed on the mobile device.
Patent AU-2012200214-B2 (AU)
Title: Compounds and compositions for delivering active agents
Inventor: LEONE-BAY ANDREA
IPC: A01N37/44
Filed: 2012-01-13
Granted: 2013-10-24
Abstract: COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS Compounds and compositions for the delivery of active agents are provided. Methods of administration and preparation are provided as well.
Patent AU-2012205175-B2 (AU)
Title: Stimulus method for releasing stress, and stress-free medical treatment method by the stimulus method
Inventor: RYOTOKUJI KENJI
IPC: A61H39/00
Filed: 2012-07-17
Granted: 2015-01-29
Abstract: In a stimulus method, a stimulus applying apparatus is attached to an area selected from a group of specific parts of a body surface by an acupuncture needle(s) or heating etc. thereby S releasing the stress, and a stress-free medical treatment method based on the stimulus method.